Jason Voss, CFA, looks at US Treasury yields, the flood of new corporate debt issuance, the emerging market resurgence, and other fixed-income surprises from 2014.
It may seem an odd question, but can financial engineering cure cancer? No less an intellectual light than Andrew W. Lo of MIT thinks financial engineering is a possibly potent weapon to aid in the ages old pursuit for a cancer cure.
Today’s most shared: MF Global customers made whole, 2 years later… Another day, another claim of benchmark-rigging, this time it’s Brent crude… Wealth tax proposals gain currency… Will Fed taper, but lengthen low-rate guidance, lower… READ MORE ›